White House wants to hear your supply-chain issues
BIO has been hearing from members experiencing issues accessing manufacturing components, ancillary materials, and raw materials, as well as with securing time for manufacturing runs...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
BIO has been hearing from members experiencing issues accessing manufacturing components, ancillary materials, and raw materials, as well as with securing time for manufacturing runs...
Qx Therapeutics reports that the FDA has cleared the company’s Investigational New Drug application for investigating its lead investigational drug product, QXT-101, for a Phase 2...
UConn associate professor of pharmaceutics Xiuling Lu, and professor of chemistry Rajeswari M. Kasi were part of a team that recently found that a commonly-used drug may be...
Bioasis Technologies has formed a research collaboration with Aposense Limited. Aposense is an Israeli bio-pharmaceutical company specializing in the development of novel drugs utilizing membrane electrical forces...
Vanessa Biotech has secured an orphan drug designation for Shylicine™, the only treatment of its kind developed for microvillus inclusion disorder, a rare and often lethal...
Nine years ago, a half-dozen professors at Yale and other universities envisioned a life sciences system that would aid researchers and drugmakers in evaluating how...
Boehringer Ingelheim, the German pharma giant whose North American headquarters are in Ridgefield, reports that despite the pandemic, it maintained momentum in 2020. The company...
The trade publication Fierce MedTech has chosen both Branford-based Yale spinout IsoPlexis and Guilford-based portable MRI maker Hyperfine Research for its 2020 “Fierce 15.” “Each...
CytoVeris reports the extension of its research partnership with Yale University. The collaboration continues to build and validate an AI-driven ‘smart’ algorithm which serves as the...
Dr. Aaron Ring, an assistant professor of immunobiology at Yale, is piloting a new approach to targeting cancerous tumors that has not only drawn the eyes...